Publishing research using ab134161? Please let us know so that we can cite the reference in this datasheet.
ab134161 has been referenced in 6 publications.
- Xu Z et al. High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder. Oncol Lett 15:6519-6526 (2018). PubMed: 29725402
- Seaman S et al. Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature. Cancer Cell 31:501-515.e8 (2017). WB, IP, IHC-Fr, Flow Cyt ; Mouse, Human . PubMed: 28399408
- Wilson KE et al. Spectroscopic Photoacoustic Molecular Imaging of Breast Cancer using a B7-H3-targeted ICG Contrast Agent. Theranostics 7:1463-1476 (2017). PubMed: 28529630
- Zhang W et al. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity. Int J Oncol 46:2562-72 (2015). WB . PubMed: 25872657
- Zhang W et al. B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells. Onco Targets Ther 8:1721-33 (2015). WB ; Human . PubMed: 26203263
- Hasegawa K et al. Chromosomal gain promotes formation of a steep RanGTP gradient that drives mitosis in aneuploid cells. J Cell Biol 200:151-61 (2013). WB, ICC/IF ; Human . PubMed: 23319601